Ontology highlight
ABSTRACT:
INSTRUMENT(S): timsTOF Pro
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Lung, Permanent Cell Line Cell
DISEASE(S): Lung Small Cell Carcinoma
SUBMITTER: Janos Demeter
LAB HEAD: Julian Sage
PROVIDER: PXD017704 | Pride | 2020-06-17
REPOSITORIES: Pride
Items per page: 5 1 - 5 of 288 |
Coles Garry L GL Cristea Sandra S Webber James T JT Levin Rebecca S RS Moss Steven M SM He Andy A Sangodkar Jaya J Hwang Yeonjoo C YC Arand Julia J Drainas Alexandros P AP Mooney Nancie A NA Demeter Janos J Spradlin Jessica N JN Mauch Brandon B Le Vicky V Shue Yan Ting YT Ko Julie H JH Lee Myung Chang MC Kong Christina C Nomura Daniel K DK Ohlmeyer Michael M Swaney Danielle L DL Krogan Nevan J NJ Jackson Peter K PK Narla Goutham G Gordan John D JD Shokat Kevan M KM Sage Julien J
Cancer cell 20200611 1
Using unbiased kinase profiling, we identified protein kinase A (PKA) as an active kinase in small cell lung cancer (SCLC). Inhibition of PKA activity genetically, or pharmacologically by activation of the PP2A phosphatase, suppresses SCLC expansion in culture and in vivo. Conversely, GNAS (G-protein α subunit), a PKA activator that is genetically activated in a small subset of human SCLC, promotes SCLC development. Phosphoproteomic analyses identified many PKA substrates and mechanisms of actio ...[more]